157 related articles for article (PubMed ID: 19688630)
1. Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons.
Nguyen TB; Lucero GR; Chana G; Hult BJ; Tatro ET; Masliah E; Grant I; Achim CL; Everall IP;
J Neurovirol; 2009 Sep; 15(5-6):434-8. PubMed ID: 19688630
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity.
Wang W; Yang Y; Ying C; Li W; Ruan H; Zhu X; You Y; Han Y; Chen R; Wang Y; Li M
Neuropharmacology; 2007 Jun; 52(8):1678-84. PubMed ID: 17517424
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
Koh SH; Noh MY; Kim SH
Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons.
Sui Z; Sniderhan LF; Fan S; Kazmierczak K; Reisinger E; Kovács AD; Potash MJ; Dewhurst S; Gelbard HA; Maggirwar SB
Eur J Neurosci; 2006 May; 23(10):2623-34. PubMed ID: 16817865
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells.
Lee KY; Koh SH; Noh MY; Park KW; Lee YJ; Kim SH
Brain Res; 2007 Jan; 1129(1):89-99. PubMed ID: 17157278
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.
Ramirez SH; Fan S; Zhang M; Papugani A; Reichenbach N; Dykstra H; Mercer AJ; Tuma RF; Persidsky Y
Am J Pathol; 2010 Feb; 176(2):881-92. PubMed ID: 20056834
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
[TBL] [Abstract][Full Text] [Related]
8. Potential Role of Glycogen Synthase Kinase-3β in Regulation of Myocardin Activity in Human Vascular Smooth Muscle Cells.
Zhou YX; Shi Z; Singh P; Yin H; Yu YN; Li L; Walsh MP; Gui Y; Zheng XL
J Cell Physiol; 2016 Feb; 231(2):393-402. PubMed ID: 26129946
[TBL] [Abstract][Full Text] [Related]
9. Potential therapeutic effect of glycogen synthase kinase 3beta inhibition against human glioblastoma.
Miyashita K; Kawakami K; Nakada M; Mai W; Shakoori A; Fujisawa H; Hayashi Y; Hamada J; Minamoto T
Clin Cancer Res; 2009 Feb; 15(3):887-97. PubMed ID: 19188159
[TBL] [Abstract][Full Text] [Related]
10. Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
Carter YM; Kunnimalaiyaan S; Chen H; Gamblin TC; Kunnimalaiyaan M
Cancer Biol Ther; 2014 May; 15(5):510-5. PubMed ID: 24521712
[TBL] [Abstract][Full Text] [Related]
11. AR-A014418 as a glycogen synthase kinase-3 inhibitor: anti-apoptotic and therapeutic potential in experimental spinal cord injury.
Tunçdemir M; Yıldırım A; Karaoğlan A; Akdemir O; Oztürk M
Neurocirugia (Astur); 2013; 24(1):22-32. PubMed ID: 23116585
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylation.
Selenica ML; Jensen HS; Larsen AK; Pedersen ML; Helboe L; Leist M; Lotharius J
Br J Pharmacol; 2007 Nov; 152(6):959-79. PubMed ID: 17906685
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.
Yeste-Velasco M; Folch J; Trullàs R; Abad MA; Enguita M; Pallàs M; Camins A
Neuropharmacology; 2007 Aug; 53(2):295-307. PubMed ID: 17612578
[TBL] [Abstract][Full Text] [Related]
15. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.
Bhat R; Xue Y; Berg S; Hellberg S; Ormö M; Nilsson Y; Radesäter AC; Jerning E; Markgren PO; Borgegård T; Nylöf M; Giménez-Cassina A; Hernández F; Lucas JJ; Díaz-Nido J; Avila J
J Biol Chem; 2003 Nov; 278(46):45937-45. PubMed ID: 12928438
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
17. alpha-Amino-3-hydroxy-5-methyl-4-isoxazole propionate attenuates glutamate-induced caspase-3 cleavage via regulation of glycogen synthase kinase 3beta.
Nishimoto T; Kihara T; Akaike A; Niidome T; Sugimoto H
J Neurosci Res; 2008 Apr; 86(5):1096-105. PubMed ID: 18041091
[TBL] [Abstract][Full Text] [Related]
18. Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
Guendel I; Iordanskiy S; Van Duyne R; Kehn-Hall K; Saifuddin M; Das R; Jaworski E; Sampey GC; Senina S; Shultz L; Narayanan A; Chen H; Lepene B; Zeng C; Kashanchi F
J Virol; 2014 Jan; 88(2):1189-208. PubMed ID: 24227837
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
Rosa AO; Kaster MP; Binfaré RW; Morales S; Martín-Aparicio E; Navarro-Rico ML; Martinez A; Medina M; García AG; López MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1549-56. PubMed ID: 18579278
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma.
Abe K; Yamamoto N; Domoto T; Bolidong D; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Inatani H; Aoki Y; Higuchi T; Taniguchi Y; Yonezawa H; Araki Y; Aiba H; Minamoto T; Tsuchiya H
Cancer Sci; 2020 Feb; 111(2):429-440. PubMed ID: 31808966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]